Change in survival in metastatic breast cancer with treatment advances: meta-analysis and systematic review
JL Caswell-Jin, SK Plevritis, L Tian… - JNCI cancer …, 2018 - academic.oup.com
Background Metastatic breast cancer (MBC) treatment has changed substantially over time,
but we do not know whether survival post-metastasis has improved at the population level …
but we do not know whether survival post-metastasis has improved at the population level …
Threats to validity of nonrandomized studies of postdiagnosis exposures on cancer recurrence and survival
J Chubak, DM Boudreau, HS Wirtz… - Journal of the …, 2013 - academic.oup.com
Studies of the effects of exposures after cancer diagnosis on cancer recurrence and survival
can provide important information to the growing group of cancer survivors. Observational …
can provide important information to the growing group of cancer survivors. Observational …
Patterns of metachronous metastases after curative treatment of colorectal cancer
YRBM van Gestel, IHJT de Hingh… - Cancer …, 2014 - Elsevier
Background This study aimed to provide information on timing, anatomical location, and
predictors for metachronous metastases of colorectal cancer based on a large consecutive …
predictors for metachronous metastases of colorectal cancer based on a large consecutive …
Overall survival associated with CDK4/6 inhibitors in patients with HR+/HER2–metastatic breast cancer in the United States: A SEER‐Medicare population‐based …
Background Evidence on overall survival (OS) with cyclin‐dependent kinase 4 and 6
(CDK4/6) inhibitors is generally limited to data from clinical trials or a few observational …
(CDK4/6) inhibitors is generally limited to data from clinical trials or a few observational …
Association of serum level of vitamin D at diagnosis with breast cancer survival: a case-cohort analysis in the pathways study
Importance There are long-standing interests in the potential benefits of vitamin D for
preventing breast cancer recurrence and mortality, yet data from prospective cohort studies …
preventing breast cancer recurrence and mortality, yet data from prospective cohort studies …
Racial and ethnic bias in risk prediction models for colorectal cancer recurrence when race and ethnicity are omitted as predictors
S Khor, EC Haupt, EE Hahn, LJL Lyons… - JAMA Network …, 2023 - jamanetwork.com
Importance Including race and ethnicity as a predictor in clinical risk prediction algorithms
has received increased scrutiny, but there continues to be a lack of empirical studies …
has received increased scrutiny, but there continues to be a lack of empirical studies …
Using natural language processing to improve efficiency of manual chart abstraction in research: the case of breast cancer recurrence
DS Carrell, S Halgrim, DT Tran… - American journal of …, 2014 - academic.oup.com
The increasing availability of electronic health records (EHRs) creates opportunities for
automated extraction of information from clinical text. We hypothesized that natural language …
automated extraction of information from clinical text. We hypothesized that natural language …
Natural language processing to identify advance care planning documentation in a multisite pragmatic clinical trial
C Lindvall, CY Deng, E Moseley, N Agaronnik… - Journal of pain and …, 2022 - Elsevier
Context Large multisite clinical trials studying decision-making when facing serious illness
require an efficient method for abstraction of advance care planning (ACP) documentation …
require an efficient method for abstraction of advance care planning (ACP) documentation …
Natural language processing to identify cancer treatments with electronic medical records
J Zeng, I Banerjee, AS Henry, DJ Wood… - JCO Clinical Cancer …, 2021 - ascopubs.org
PURPOSE Knowing the treatments administered to patients with cancer is important for
treatment planning and correlating treatment patterns with outcomes for personalized …
treatment planning and correlating treatment patterns with outcomes for personalized …
Using natural language processing to construct a metastatic breast cancer cohort from linked cancer registry and electronic medical records data
Objectives Most population-based cancer databases lack information on metastatic
recurrence. Electronic medical records (EMR) and cancer registries contain complementary …
recurrence. Electronic medical records (EMR) and cancer registries contain complementary …